- Home
- ASPS vs IMA Comparison
ASPS vs IMA Comparison
Compare ASPS & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASPS | IMA |
|---|---|---|
| Founded | 1999 | 2019 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.5M | 66.3M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ASPS | IMA |
|---|---|---|
| Price | $5.75 | $4.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 11.3K | ★ 13.9K |
| Earning Date | 10-26-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $942,213,000.00 | $800,000.00 |
| Revenue This Year | $16.74 | N/A |
| Revenue Next Year | $9.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.30 | $3.90 |
| 52 Week High | $12.46 | $9.10 |
Technical Indicators
Market Signals| Indicator | ASPS | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 19.96 |
| Support Level | $5.17 | $3.92 |
| Resistance Level | $6.03 | $6.10 |
| Average True Range (ATR) | 0.41 | 0.17 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 21.32 | 12.05 |
Price Performance
Historical ComparisonAbout ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.